Pawel Strozecki
Overview
Explore the profile of Pawel Strozecki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Badurek S, Strozecki P, Zawadzka J
Pol Arch Intern Med
. 2024 Aug;
134(11).
PMID: 39189144
No abstract available.
2.
Strozecki P, Bednarski R, Skoczylas-Makowska N, Grzanka D
Pol Arch Intern Med
. 2024 Feb;
134(3).
PMID: 38324327
No abstract available.
3.
Strozecki P, Pluta A, Donderski R, Wlodarczyk Z, Manitius J
Blood Press Monit
. 2020 Nov;
26(1):22-29.
PMID: 33234809
Objective: Chronic kidney disease (CKD) is associated with high cardiovascular risk. Prevalence of hypertension and hypertension-mediated organ damage (HMOD) increases with CKD progression. Nocturnal blood pressure (BP) is a strong...
4.
Donderski R, Strozecki P, Sulikowska B, Grajewska M, Trafny R, Bodnar M, et al.
Kidney Blood Press Res
. 2018 Jun;
43(3):1042-1052.
PMID: 29940595
Background/aims: Cardiovascular complications are responsible for increased mortality and morbidity in chronic kidney disease (CKD) patients. Functional and structural changes of peritoneal membrane are reported in CKD patients both on...
5.
Strozecki P, Ostrowski J, Majczynska I, Sulikowska B, Odrowaz-Sypniewska G, Stefanska A, et al.
EJIFCC
. 2018 Jun;
16(4):100-102.
PMID: 29899684
No abstract available.
6.
Pluta A, Strozecki P, Kesy J, Lis K, Sulikowska B, Odrowaz-Sypniewska G, et al.
Biomed Res Int
. 2018 Jan;
2017:1680985.
PMID: 29349065
Introduction: Chronic kidney disease (CKD) is accompanied by inflammation. The aim of this study was to evaluate the effect of 6-month supplementation with omega-3 acids on selected markers of inflammation...
7.
Donderski R, Strozecki P, Sulikowska B, Grajewska M, Miskowiec I, Stefanska A, et al.
Int Urol Nephrol
. 2017 Jul;
49(10):1867-1873.
PMID: 28710615
Background: High aldosterone level may contribute to pathogenesis of hypertension, vessels damage and cardiovascular system deterioration in chronic kidney disease patients. Besides its classical action via mineralocorticoid receptor, aldosterone is...
8.
Kaminski R, Strozecki P, Kosinski A, Grzybiak M
J Vasc Access
. 2015 Oct;
17(1):e5-6.
PMID: 26450081
No abstract available.
9.
Pluta A, Strozecki P, Krintus M, Odrowaz-Sypniewska G, Manitius J
Ren Fail
. 2015 Jul;
37(7):1105-10.
PMID: 26156686
Introduction: Chronic kidney disease (CKD) is an independent factor for cardiovascular system complications, such as arterial hypertension, left ventricular hypertrophy (LVH), heart failure or accelerated atherosclerosis progression. The aim of...
10.
Strozecki P, Serafin Z, Adamowicz A, Flisinski M, Wlodarczyk Z, Manitius J
Adv Med Sci
. 2015 May;
60(2):240-5.
PMID: 25951498
Purpose: Coronary artery calcification (CAC) is an independent predictor of cardiovascular (CV) events in renal transplant recipients (RTR). Carotid-femoral pulse wave velocity (PWV), a non-invasive measure of large artery stiffness,...